[JOINT FILING AGREEMENT Joint Filing Agreement This Agreement may be executed in counterparts and each of such counterparts taken together shall constitute one and the same instrument. Dated Morgan Stanley MSRESS III, Inc. MSRESS III Manager, L.L.C.]
[SHARE TRANSFER CONTRACT OF SHAANXI WEINAN HUAREN PHARMACEUTICALS CO., LTD. BY AND BETWEEN SHAANXI AOXING PHARMACEUTICALS CO., LTD. AND SHAREHOLDERS OF SHAANXI WEINAN HUAREN PHARMACEUTICALS CO., LTD. INDEX CHAPATER I DEFINITION AND INTERPRETATION 4 ARTICLE 1 DEFINITION 4 CHAPATER II TRANSFERRED SHARES 5 ARTICLE 2 SHARE TRANSFER 5 ARTICLE 3 TRANSFER PRICE 5 ARTICLE 4 CONDITIONS FOR THE PAYMENT OF] [Form Non-competition Agreement Agreement This Non-competition Agreement (this “ Party A: Shaanxi Weinan Huaren Pharmaceuticals Co., Ltd., a company incorporated under PRC law, with its business license registered number [_] and its legal address registered at No. 13, Weihua Road, Weinan City, Shaanxi Province; Party B: [_], a PRC citizen with the ID number [_]. Whereas Equity Interests Article 1] [BIOSTAR PHARMACEUTICALS SIGNS AGREEMENT TO ACQUIRE SHAANXI WEINAN HUAREN PHARMACEUTICALS, LTD . XIANYANG, China, October 11, 2011 -- Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a developer, manufacturer and marketer of pharmaceutical and health supplement products for a variety of diseases and conditions, today announced that its wholly owned subsidiary, Shaanxi Aoxing Pharmaceutical, Ltd., entered into a]
[SHARE TRANSFER CONTRACT OF SHAANXI WEINAN HUAREN PHARMACEUTICALS CO., LTD. BY AND BETWEEN SHAANXI AOXING PHARMACEUTICALS CO., LTD. AND SHAREHOLDERS OF SHAANXI WEINAN HUAREN PHARMACEUTICALS CO., LTD. INDEX CHAPATER I DEFINITION AND INTERPRETATION 4 ARTICLE 1 DEFINITION 4 CHAPATER II TRANSFERRED SHARES 5 ARTICLE 2 SHARE TRANSFER 5 ARTICLE 3 TRANSFER PRICE 5 ARTICLE 4 CONDITIONS FOR THE PAYMENT OF] [Form Non-competition Agreement Agreement This Non-competition Agreement (this “ Party A: Shaanxi Weinan Huaren Pharmaceuticals Co., Ltd., a company incorporated under PRC law, with its business license registered number [_] and its legal address registered at No. 13, Weihua Road, Weinan City, Shaanxi Province; Party B: [_], a PRC citizen with the ID number [_]. Whereas Equity Interests Article 1] [BIOSTAR PHARMACEUTICALS SIGNS AGREEMENT TO ACQUIRE SHAANXI WEINAN HUAREN PHARMACEUTICALS, LTD . XIANYANG, China, October 11, 2011 -- Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a developer, manufacturer and marketer of pharmaceutical and health supplement products for a variety of diseases and conditions, today announced that its wholly owned subsidiary, Shaanxi Aoxing Pharmaceutical, Ltd., entered into a]
[[Letterhead of NetEase.com,Inc.] October11 , 2011 Ms.Mara Ransom Ms.Angie Kim Mr.William H. Thompson Mr.Adam Phippen Division ofrporation Finance 100 F Street, N.E. Re: NetEase.com,Inc. (thempany) Form20-F for the Fiscal Year Ended December31, 2010 Filed June22, 2011 File No.0-30666 (the 2010 Form20-F) Dear Ms.Ransom, Ms.Kim, Mr.Thompson and Mr.Phippen: In your letterted September27, 2011, you requested that]
[[Letterhead of NetEase.com,Inc.] October11 , 2011 Ms.Mara Ransom Ms.Angie Kim Mr.William H. Thompson Mr.Adam Phippen Division ofrporation Finance 100 F Street, N.E. Re: NetEase.com,Inc. (thempany) Form20-F for the Fiscal Year Ended December31, 2010 Filed June22, 2011 File No.0-30666 (the 2010 Form20-F) Dear Ms.Ransom, Ms.Kim, Mr.Thompson and Mr.Phippen: In your letterted September27, 2011, you requested that]
[Item 1: Reporting Person - FMR LLC Item 4: Delaware Item 5: 0 Item 6: 0 Item 7: 0 Item 8: 0 Item 9: 0 Item 11: 0.000% Item 12: HC Cusip #47759T928 Item 1: Reporting Person - Edward C. Johnson 3d Item 5: 0 Item 6: 0 Item 7: 0 Item 8: 0 Item 9: 0 Item 11: 0.000%]
[Form 6-K TABLE OF CONTENTS Page 3 4]
[Form 6-K TABLE OF CONTENTS Page 3 4]
[OSSEN INNOVATION CO., LTD. 518 Shangcheng Road, Floor 17 Shanghai, 200120 People’s Republic of China. NOTICE OF ANNUAL MEETING OF SHAREHOLDERS To be held November 8, 2011 To the Shareholders of Ossen Innovation Co., Ltd. Notice is hereby given that the Annual Meeting of the Shareholders of Ossen Innovation Co., Ltd. (the “Company”) will be held on November 8, 2011] [OSSEN INNOVATION CO., LTD.]
